Document Detail


Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure.
MedLine Citation:
PMID:  2403515     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Management of patients with the adult respiratory distress syndrome should be directed toward maintaining adequate cardiac output and tissue oxygenation without exacerbating pulmonary edema. The aim of therapy should be to maintain low left ventricular filling pressure, which will tend to decrease the rate of edema formation. If cardiac output is low or decreases as a function of therapy, flow may be increased with inotropic agents. When a marked decline in cardiac output complicates pulmonary embolism, norepinephrine may be an excellent drug for at least short-term maintenance of hemodynamic stability. When a moderate decrease in cardiac output complicates an increase in right ventricular afterload, isoproterenol or dobutamine may be used to increase flow. Rapid administration of recombinant tissue plasminogen activator may be the treatment of choice of pulmonary thromboembolism associated with a low output state.
Authors:
R M Prewitt
Related Documents :
15283355 - Total cavopulmonary connection to one lung.
8295505 - The pulmonary artery acceleration time determined with the mr-race-technique: compariso...
986695 - The lung: responses to trauma, surgery, and sepsis.
8540445 - Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension aft...
7146885 - Subacute pulmonary hypertension and systemic tumour embolism from cervical cancer.
16275465 - Giant cell arteritis manifesting as mesenteric ischemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care medicine     Volume:  18     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-02-06     Completed Date:  1990-02-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S61-9     Citation Subset:  AIM; IM    
Affiliation:
Section of Cardiology, University of Manitoba, Winnipeg, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Anoxia / physiopathology*,  therapy
Cardiac Output / drug effects
Cardiac Output, Low / physiopathology
Cardiotonic Agents / therapeutic use
Combined Modality Therapy
Dogs
Fibrinolytic Agents / therapeutic use
Hemodynamics*
Humans
Pulmonary Embolism / physiopathology*,  therapy
Respiratory Distress Syndrome, Adult / therapy
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heart failure in septic shock: effects of inotropic support.
Next Document:  Septic shock: particular type of acute circulatory failure.